Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 8, 2022
Reporting Period: Third quarter ended September 30, 2022
Business Context: The filing serves as a notification of the Company's announcement of financial results for the third quarter of 2022. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
The provided text is a cover page and index for the Form 8-K. It references a press release (Exhibit 99.1) containing the actual financial data but does not include the specific figures within this document.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific numerical comparisons or material changes versus the prior comparable period. It only confirms that results for the third quarter ended September 30, 2022, were announced.
Guidance, Outlook, and Risks
Management Commentary: The text states that the full text of the press release regarding the results is furnished as Exhibit 99.1. No specific commentary, guidance, or outlook is contained in the body of this 8-K filing.
Risks and Contingencies: No specific risks or contingencies are detailed in this document. The filing includes a standard disclaimer that the information furnished in Item 2.02 and Exhibit 99.1 is not deemed "filed" under the Exchange Act for liability purposes.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 8, 2022) for actual revenue, net loss, and cash position figures.
- Verify the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.
- Confirm the trading symbol (IDYA) and exchange (Nasdaq Global Select Market) for accurate market data retrieval.
- Check subsequent filings for the full Form 10-Q to obtain audited or reviewed financial statements for the period.